NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 335 / 982

  1. No smoking gun: tobacco taxation and smuggling in Sierra Leone2022 · Crossref
  2. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment2022 · OpenAlex
  3. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss2022 · OpenAlex
  4. NON-DESTRUCTIVE METHOD TO DETERMINING THE LEAF AREA IN HEMP, Cannabis sativa L.2022 · Crossref
  5. Non-fentanyl-derived synthetic opioids emerging during recent years2022 · OpenAlex
  6. Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing2022 · OpenAlex
  7. Non-sedative cortical EEG signatures of allopregnanolone and functional comparators2022 · OpenAlex
  8. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers2022 · Crossref
  9. Noncoding RNA therapeutics for substance use disorder2022 · Crossref
  10. Noncoding RNAs in oral cancer2022 · OpenAlex
  11. Noncommunicable diseases and health system responses in Saudi Arabia: focus on policies and strategies. A qualitative study2022 · Crossref
  12. Nondestructive Detection of Stem Content in Tobacco Strips Using X-Ray Imaging Analysis2022 · Crossref
  13. Nonfatal opioid-related overdoses treated by emergency medical services in Florida, before and during the COVID-19 pandemic2022 · OpenAlex
  14. Nonmedical use of Prescription Drugs and Biopsychosocial Correlates among Females who are Sex Workers in China2022 · Crossref
  15. Non‐convulsive status epilepticus in the setting of cannabidiol adjunctive therapy2022 · Crossref
  16. Non‐drinking 101: How non‐drinkers navigate the drinking culture on a college campus2022 · Crossref
  17. Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis2022 · Crossref
  18. Non‐psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors‐, endocannabinoids‐, and NF‐κB ‐mediated signaling2022 · OpenAlex
  19. Non‐small cell lung cancer in China2022 · OpenAlex
  20. NORMA PENGGUNAAN VERBA DISCLOSE DAN REVEAL PADA CORPUS OF CONTEMPORARY AMERICAN ENGLISH (COCA): KAJIAN LINGUISTIK KORPUS2022 · Crossref
  21. Norms, rules and policy tools: understanding Article 5.3 as an instrument of tobacco control governance2022 · Crossref
  22. Not on Skid Row: Stigma Management in Addiction Treatment Organizations2022 · Crossref
  23. Notes from the Field: HIV Outbreak During the COVID-19 Pandemic Among Persons Who Inject Drugs — Kanawha County, West Virginia, 2019–20212022 · OpenAlex
  24. Notes from the Field: Increase in Drug Overdose Deaths Among Hispanic or Latino Persons — Nevada, 2019–20202022 · OpenAlex
  25. Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID2022 · OpenAlex
  26. Noticing people, discounts and non-tobacco flavours in e-cigarette ads may increase e-cigarette product appeal among non-tobacco-using young adults2022 · Crossref
  27. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.2022 · PubMed
  28. Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry2022 · OpenAlex
  29. Novel Cognitions in Allelopathy: Implications from the “Horizontal Natural Product Transfer”2022 · Crossref
  30. Novel Dopamine Transporter Inhibitor, CE-123, Ameliorates Spatial Memory Deficits Induced by Maternal Separation in Adolescent Rats: Impact of Sex2022 · OpenAlex
  31. Novel drug developmental strategies for treatment-resistant depression.2022 · PubMed
  32. Novel ethical and policy issues in psychiatric uses of psychedelic substances2022 · OpenAlex
  33. Novel Insights into Potential Cannabis-Related Cancerogenesis from Recent Key Whole Epigenome Screen of Cannabis Dependence and Withdrawal: Epidemiological Commentary and Explication of Schrott et al.2022 · Crossref
  34. Novel Insights into the Nature of Intraspecific Genome Size Diversity in Cannabis sativa L.2022 · Crossref
  35. Novel Methods of Cannabis Use and Lower Sleep Duration Among High School Students2022 · Crossref
  36. Novel Pharmacological Approaches to the Treatment of Depression2022 · OpenAlex
  37. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–20192022 · OpenAlex
  38. Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse2022 · Crossref
  39. NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches2022 · OpenAlex
  40. Nuancing Drug Harms: Exploring the Context of Substance Use Among Street-Involved Women in Uyo, Nigeria2022 · Crossref
  41. Nucleation increases the visual appeal of lager but does not alter overall likeability or drinking rate2022 · Crossref
  42. Nuevos espacios clínicos para Cannabis sativa y hongos Psilocibe en Chile2022 · Crossref
  43. Nurses’ substance use disorder in disciplinary procedures: A retrospective document analysis2022 · Crossref
  44. Nursing Care Needs Assessment of Persons with Substance Use Disorder2022 · Crossref
  45. Nursing Students' Use of Harm Reduction in the Clinical Setting2022 · Crossref
  46. Nutmeg ( Myristica fragrans Houtt.) essential oil: A review on its composition, biological, and pharmacological activities2022 · OpenAlex
  47. Nutraceutical potential of industrial hemp ( Cannabis sativa L.) extracts: physicochemical stability and bioaccessibility of cannabidiol (CBD) nanoemulsions2022 · Crossref
  48. Nutraceuticals of nano-betel (Piper betle L.) leaves: prevent COVID-19 and oral cavity disease2022 · OpenAlex
  49. Nutraceuticals: A source of benefaction for neuropathic pain and fibromyalgia2022 · OpenAlex
  50. Nutrient digestibility, rumen parameters, and (cannabinoid) residues in sheep fed a pelleted diet containing green hemp (Cannabis sativa L.) biomass2022 · Crossref
  51. Nutrients and Main Secondary Metabolites Characterizing Extracts and Essential Oil from Fruits of Ammodaucus leucotrichus Coss. & Dur. (Western Sahara)2022 · Crossref
  52. Nutrition and mental health: A review of current knowledge about the impact of diet on mental health2022 · OpenAlex
  53. Nutritional Quality, Chemical, and Functional Characteristics of Hemp (Cannabis sativa ssp. sativa) Protein Isolate2022 · Crossref
  54. Nutritional status, alcohol-tobacco consumption behaviour and cognitive decline among older adults in India2022 · Crossref
  55. Nutritional value and antioxidant properties of Cannabis seeds from Makwanpur district of central Nepal2022 · OpenAlex
  56. O emprego da Cannabis medicinal no enfrentamento à doenças2022 · Crossref
  57. O estigma do traficante: guerra às drogas, a deterioração da identidade do criminalizado / The stigma of the trafficker: war on drugs, the deterioration of the identity of the criminalized2022 · Crossref
  58. O mecanismo de ação da Cannabis sativa L. enquanto indutora do sono e suas consequências neuropsicológicas - uma revisão integrativa2022 · Crossref
  59. O Piper Methysticum G. Forster, CONHECIDO POPULARMENTE COMO Kava-Kava, NA LUTA CONTRA ANSIEDADE.2022 · Crossref
  60. O Renascimento da Medicina Psicodélica2022 · Crossref
  61. O USO DE CANABINOIDES DE CANNABIS SATIVA L. NO TRATAMENTO DA EPILEPSIA: UMA REVISÃO INTEGRATIVA2022 · Crossref
  62. O uso de cannabis no tratamento de fobia social, um estudo abrangente de seus efeitos e controvérsias / The use of cannabis in the treatment of social phobia, a comprehensive study of its effects and controversies2022 · Crossref
  63. O uso de Cannabis sativa no tratamento de Alzheimer2022 · Crossref
  64. O uso de medicamentos psicoativos entre os profissionais de saúde2022 · Crossref
  65. O uso medicinal da Cannabis sativa L.: regulamentação, desafios e perspectivas no Brasil2022 · Crossref
  66. O uso terapêutico da cannabis sativa em pacientes portadores deepilepsia: a percepção de acadêmicos do curso de enfermagem de uma faculdade no sudoeste goiano2022 · Crossref
  67. Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes2022 · Crossref
  68. Observations on 25 Years of Cannabis Law Reforms and Their Implications for the Psychedelic Renaissance in the United States2022 · OpenAlex
  69. Occupational contact urticaria to cannabis sativa2022 · Crossref
  70. Occupational health care personnel tackling alcohol overuse – an observational study of work processes and patient characteristics2022 · Crossref
  71. Occupational roles and risks of community-embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya2022 · OpenAlex
  72. Occurrence, distribution, and ecological risk of psychoactive substances in typical lakes and rivers in Qinghai-Tibet Plateau2022 · OpenAlex
  73. Occurrence, fate and determination of tobacco (nicotine) and alcohol (ethanol) residues in waste- and environmental waters2022 · OpenAlex
  74. Occurrence, hazard, and risk of psychopharmaceuticals and illicit drugs in European surface waters2022 · OpenAlex
  75. ODP165 Atypical DKA? Think Cannabis!2022 · Crossref
  76. Of pharmakon: Hallucination in Amerindian perspectivism and speculative materialism2022 · OpenAlex
  77. Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review2022 · Crossref
  78. Oklahoma Tobacco Helpline Utilization and Outcomes by Diabetes Status2022 · Crossref
  79. Old and New Hypothesis to The Mechanism Underlying Opioid Addiction and A Novel Treatment – A Review2022 · Crossref
  80. OLDER ADULTS' PERCEPTIONS OF CANNABIS AND OPIOIDS USE2022 · Crossref
  81. Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome2022 · Crossref
  82. On Determination of Behavioural Characteristics Responsible for Psychopathic Personality Traits2022 · Crossref
  83. On Qualification of Crimes Related to Illicit Trafficking in Narcotic Drugs and Psychotropic Substances2022 · Crossref
  84. On the problem of alcoholic cocktails in Russia2022 · Crossref
  85. On the Role of Stimulus-Response Context in Inhibitory Control in Alcohol Use Disorder2022 · Crossref
  86. On-site illicit-drug detection with an integrated near-infrared spectral sensor: A proof of concept2022 · OpenAlex
  87. ONDCP national strategy includes focus on treatment, harm reduction2022 · Crossref
  88. ONDCP: Improving drug crisis response requires data on nonfatal overdoses2022 · Crossref
  89. One Image is Worth more than a Thousand Words: Producing an Atlas of Medical Signs for Teaching Clinical and Forensic Toxicology2022 · Crossref
  90. One Year Mortality of Patients Treated with Naloxone for Opioid Overdose by Emergency Medical Services2022 · Crossref
  91. One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits2022 · Crossref
  92. One-step extraction and determination of 513 psychoactive substances, drugs, and their metabolites from hair by LC–MS/MS2022 · Crossref
  93. Onkolojik Aciller ve Hemşirelik Yönetimi: Vena Kava Süperior Sendromu2022 · Crossref
  94. Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations2022 · Crossref
  95. Online Sex Addiction: A Qualitative Analysis of Symptoms in Treatment-Seeking Men2022 · Crossref
  96. On‐site forensic analysis of colored seized materials: Detection of brown heroin and MDMA‐tablets by a portable NIR spectrometer2022 · OpenAlex
  97. Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone2022 · Crossref
  98. Operational response: Policing persons with mental illness in Australia2022 · Crossref
  99. Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study2022 · OpenAlex
  100. Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia2022 · OpenAlex